A mathematical modelling tool for unravelling the antibody-mediated effects on CTLA-4 interactions
Abstract Background Monoclonal antibodies blocking the Cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor have revolutionized the field of anti-cancer therapy for the last few years. The human T-cell-based immune responses are modulated by two contradicting signals. CTLA-4 provides a T cell inhibito...
Main Authors: | Aravindhan Ganesan, Theinmozhi Arulraj, Tahir Choulli, Khaled H. Barakat |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Medical Informatics and Decision Making |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12911-018-0606-x |
Similar Items
-
Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
by: Yinghao Zhao, et al.
Published: (2018-05-01) -
Shuffling the deck with CTLA-4 therapy: Deep sequencing of rearranged TCRB genes demonstrates T cell repertoire remodeling in cancer patients
by: Edward Cha, et al.
Published: (2018-04-01) -
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
by: Ribas Antoni, et al.
Published: (2012-11-01) -
Tremelimumab: research and clinical development
by: Comin-Anduix B, et al.
Published: (2016-03-01) -
Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis
by: Xu H, et al.
Published: (2019-07-01)